Chapter 38. Hormone Replacement Therapy and Osteoporosis Multiple Choice Identify the choice that best completes the statement or answers the question. ____ 1. The goals of therapy when prescribing hormone replacement therapy (HRT) include reducing: 1. Cardiovascular risk 2. Risk of stroke or other thromboembolic event 3. Breast cancer 4. Vasomotor symptoms ____ 2. The optimal maximum time frame for HRT or estrogen replacement therapy (ERT) is: 1. 2 years 2. 5 years 3. 10 years 4. 15 years ____ 3. Dosage changes of conjugated equine estrogen (Premarin) are made at _________ intervals. 1. 1 to 2 week 2. 2 to 4 week 3. 6 to 8 week 4. 12 week ____ 4. The advantage of vaginal estrogen preparations in the treatment of vulvovaginal atrophy and dryness is: 1. Ability to deliver higher doses of estrogen in a non-oral form 2. The vaginal cream formula provides moisture to the vaginal area 3. Relief of symptoms without increasing cardiovascular risk 4. All of the above ____ 5. Women with an intact uterus should be treated with both estrogen and progestin due to: 1. Increased risk for endometrial cancer if estrogen alone is used 2. Combination therapy provides the best relief of menopausal vasomotor symptoms 3. Reduced risk for colon cancer with combined therapy 4. Lower risk of developing blood clots with combined therapy ____ 6. Ongoing monitoring for women on ERT includes: 1. Lipid levels, repeated annually if abnormal 2. Annual health history and review of risk profile 3. Annual mammogram 4. All of the above ____ 7.
You've reached the end of your free preview.
Want to read all 4 pages?
- Winter '08
- Nursing, F. A. Davis, A. Davis Company